COVID-19 Funding Opportunities

These are funding opportunities available to medical researchers specific to the Coronavirus Disease (COVID-19). This list of funding opportunities specific to COVID-19 is updated on a regular basis.

Organization(s) Title Notice Number Activity code(s)
NIH, NIDCR, NHLBI Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) NOT-OD-21-035 333
NIDA Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects NOT-AI-21-002
NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-20-084 R01, R03, R21
NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-21-006 UH2, U34, U01
NHLBI Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 R01
NIAID Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 NOT-AI-20-065 U01
NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities NOT-MD-20-025 R01
NIEHS Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-21-002 333
NIDDK Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) RFA-DK-20-021 R01
NIMH, NCCIH, SGMRO, ODP, NIDCD, OBSSR, NEI, NIDA, NIA, NIAAA, NICHD, NCATS, ORWH, NIDCR, NINR, NIMHD Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional) PAR-20-243 R01
NIH, NCI, NHGRI, NCCIH, NINDS, ORIP, NIMHD, NIA, NIDCR, NIAID, NIAMS, NIEHS, NCATS, NIDCD, NICHD, NIDDK, NHLBI Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project NOT-OD-20-129
NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) PAR-20-237 R01
NIAID Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-051 R03, R43/R44, R41/R42
NIDCR, ORWH Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NOT-DE-20-022
NIDCR Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network NOT-DE-20-023 X01
NINDS Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NOT-NS-20-051
NIH, NLM, NIEHS, NIAMS, NIDCR, OBSSR, NIGMS, NHLBI, NCI, NIAAA, NINR, NCATS, ORWH, NHGRI, FIC, NCCIH, NIMH, THRO, NIDA, NINDS, NEI, NIMHD, NIAID, NIA, FDA, NIBIB, NIDCD, NICHD, NIDDK Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) NOT-OD-21-020
NCATS Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NOT-TR-20-028
NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-20-011
OBSSR, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NICHD, NIDDK, NIEHS, NINR, ODP, ORWH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NOT-OD-20-097
NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-020 333, R21
National Heart, Lung, and Blood Institute NHLBI NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-HL-20-759 N/A
NIMHD, NIA, NIAAA, NIMH, ODP Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NOT-MD-20-019
NCATS Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-017
NIMH, NIA, ODP, NIAAA, NIMHD Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NOT-MH-20-047
NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-016
NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-015 333, R21
NIA, NIMH Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-AG-20-022
NIAID Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV),” NOT-AI-20-030 NOT-AI-20-040
NIGMS Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-20-025
NCATS Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NOT-TR-20-011 333, U01, R21, U54
NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-DA-20-047
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV),” NOT-AI-20-030 NOT-AI-20-040
Point-of-Care Technology Research Network (POCTRN) NIBIB is urgently soliciting proposals and will provide up to $500 million across multiple projects to produce SARS-CoV-2 diagnostic tests. The Rapid Acceleration of Diagnostics (RADx) program will support all phases of product development from conceptualization and design to prototyping, performance evaluation, clinical validation, and manufacturing. Proposals will be accepted on a rolling basis starting April 29 and will be reviewed within a week of submission.
U.S. Department of Energy (DOE) The DOE National Virtual Biotechnology Laboratory (NVBL) is a resource available opening up the DOE national laboratory user facilities and specialized instrumentation to academic researchers and industry to address COVID-19. The NVBL lists all relevant DOE capabilities, such as light and neutron sources, nanoscale science centers, sequencing and bio-characterization facilities, and high performance computer facilities to help respond to COVID-19.
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Biological Technologies Office (BTO)
DARPA /BTO‘s research and investment portfolio includes combating pandemic disease, microbes as production platforms, human performance and warfighter readiness, innovative physiological interventions, and environmental and ecological exploration. DARPA will fund BTO to support on-going COVID-19 efforts and potentially to new ideas that address near-term COVID-19 challenges. HR001120S0044
Defense
Dept. of the Army — USAMRAA
Peer Reviewed Medical Research Program (PRMRP)
PRMRP open to Emerging Viral Diseases and Respiratory Health with a focus on COVID-19:

Office of Biomedical Advanced Research and Development Authority (BARDA) ǀ Broad Agency Announcement (BAA) BARDA expanded its standard broad agency announcement to accept proposals for advanced development of diagnostics, vaccines, therapeutics and other medical products for use in the current COVID-19 emergency response and future coronavirus outbreaks.
National Science Foundation (NSF) (NSF) NSF Rapid Response Research (RAPID) funding mechanism for non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.

For more federal and non-federal COVID-19 research opportunities click here.

◄ Back to Research website.

BACK TO TOP↑